ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

25-04-2024   Regulatory press release

On 4 April 2024, ADDvise Group AB (publ) (“ADDvise”) issued senior secured bonds in an amount of USD 60 million, under a total framework of USD 200 million (the “Bonds”).

Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website www.addvisegroup.com and at the Swedish Financial Supervisory Authority’s website www.fi.se. The application for admission to trading has been submitted and the first day of trading of the Bonds is estimated to be around 29 April 2024.

For further information, please contact:
Oliver Humlen, CFO
+46 (0) 70-916 26 97
oliver.humlen@addvisegroup.se

About ADDvise
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.